ImmersiveTouch Receives FDA Clearance for Advanced Augmented Reality Surgical System

Thursday, July 11, 2024

ImmersiveTouch Inc., a leading digital surgery company based in Chicago, has received FDA 510(k) clearance for its augmented reality (AR) technology platform, ImmersiveAR.

This platform enhances the company's suite of virtual surgical planning tools, which have already revolutionized cranio-maxillofacial (CMF) surgeries by condensing pre-operative planning from a week to mere minutes.

ImmersiveAR allows surgeons to simulate surgical changes to bone structures and plan aesthetic outcomes tailored to each patient's unique anatomy.

This capability minimizes errors and complications, offering hospitals an opportunity to increase reimbursement from payors while lowering healthcare costs.

The technology for its detailed anatomical imaging, which aids in anticipating complications and streamlining surgical procedures, thereby enhancing patient safety.

ImmersiveAR introduces advanced holographic visualization to replace traditional two-dimensional imaging in surgery, marking a significant advancement in intraoperative 3D visualization.

The platform integrates seamlessly into the operating room environment, allowing surgeons to interact with 3D virtual surgical plans during procedures.

This capability reduces the need for intraoperative adjustments and enhances surgical precision across various medical specialties.

ImmersiveTouch's recent achievements include strategic partnerships and expanding adoption in leading hospitals, impacting over 4,000 patients and reaffirming its transformative role in healthcare.






Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO Summit - USAHealthcare CMO Summit - USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitHealthcare CEO & Executive Strategy Summit